Positions and Honors
– Post-doctorate in Immunotherapy, in Paris, France (Hôpitaux Pitié Salpêtrière).
– PhD degree in Internal Medicine (Child and Adolescent Health) – Federal University of Rio de Janeiro, 2009
– Master’s degree (MSc) in Cellular and Molecular Biology from the Oswaldo Cruz Foundation, in the area of Immunology, 2002
– Board certified in Pediatrics and Allergy/Immunology
– Degree in Medicine from the Federal University of Rio de Janeiro (2001),
– Member of the Scientific Department of Immunodeficiencies of the National Brazilian Association of Allergy and Immunology ASBAI (2021-2022).
– Associate Professor of Pediatrics at the Institute of Childcare and Pediatrics Martagão Gesteira/UFRJ.
– Coordinator of the Pediatric Clinic II Discipline at the Faculty of Medicine at UFRJ
-Deputy coordinator of the Specialization Course in Allergy and Clinical Immunology at IPPMG/UFRJ.
– Professor of Maternal and Child Health Postgraduate Program – Federal University of Rio de Janeiro (UFRJ)
– Coordinator of the Immunodeficiencies Committee of the Brazilian Allergy Association and Immunology, regional Rio de Janeiro (ASBAI RJ)
– Member of the Allergy Scientific Committee at SOPERJ
– Member of GEBRAEH (Brazilian Study Group on Hereditary Angioedema).
Main research areas
- Clinical Pediatric Allergy/Immunology
- Primary Immunodeficiencies in Pediatrics
- Basic Immunology
Main publications
- Pinto-Mariz, F., Rodrigues Carvalho, L., Prufer De Queiroz Campos Araujo, A., De Mello, W., Gonçalves Ribeiro, M., Cunha, M.doC., Cabello, P. H., Riederer, I., Negroni, E., Desguerre, I., Veras, M., Yada, E., Allenbach, Y., Benveniste, O., Voit, T., Mouly, V., Silva-Barbosa, S. D., Butler-Browne, G., & Savino, W. (2015). CD49d is a disease progression biomarker and a potential target for immunotherapy in Duchenne muscular dystrophy. Skeletal muscle, 5, 45.
- Barthélémy, I., Pinto-Mariz, F., Yada, E., Desquilbet, L., Savino, W., Silva-Barbosa, S. D., Faussat, A. M., Mouly, V., Voit, T., Blot, S.,Butler-Browne, G. (2014). Predictive markers of clinical outcome in the GRMD dog model of Duchenne muscular dystrophy. Disease models and mechanisms, 7(11), 1253–1261.
- Pinto-Mariz, F., Carvalho, L. R., de Mello, W., Araújo, A.deQ., Ribeiro, M. G., Cunha, M.doC., Voit, T., Butler-Browne, G., Silva-Barbosa, S. D.,& Savino, W. (2010). Differential integrin expression by T lymphocytes:potential role in DMD muscle damage. Journal of neuroimmunology, 223(1-2), 128–130.
- Goudouris ES, Pinto-Mariz F, Mendonça LO, et al. Outcome of SARS-CoV-2 Infection in 121 Patients with Inborn Errors of Immunity: A Cross-Sectional Study. J Clin Immunol. 2021;41(7):1479-1489.
- França TT, Barreiros LA, Salgado RC, et al, Pinto-Mariz F, Goudouris ES et al. CD40 Ligand Deficiency in Latin America: Clinical, Immunological, and Genetic Characteristics. Journal of Clinical Immunology. 2022. 42(3):514-526.